Qianjin Pharmaceutical: Net profit in 2025 was 288 million yuan, a year-on-year increase of 24.74%.

Qianjin Pharmaceutical released its performance quick report, with a total operating income of 3.635 billion yuan in 2025, a year-on-year increase of 0.13%; net profit of 288 million yuan, a year-on-year increase of 24.74%. The main reasons for the company's performance growth are: first, the core industrial enterprises' income has maintained stable growth, and profitability has improved. Second, the acquisition of 28.92% equity of Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. and 68% equity of Hunan Qianjin Xielie Pharmaceutical Co., Ltd. started to be included in the merger according to the new equity ratio in October and November 2025, respectively.